Shanghai MicroPort Endovascular MedTech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Qing Zhu
Chief executive officer
CN¥3.9m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.5yrs |
| CEO ownership | n/a |
| Management average tenure | 3.8yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO
Qing Zhu (43 yo)
6.5yrs
Tenure
CN¥3,943,900
Compensation
Mr. Qing Zhu is GM & Director of Shanghai MicroPort Endovascular MedTech Co., Ltd. He was Deputy General Manager of Shanghai MicroPort Endovascular MedTech Co., Ltd.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥3.94m | no data | |
| Accounting Supervisor & CFO | 3.3yrs | CN¥1.21m | no data | |
| Deputy GM & Secretary of the Board of Directors | 2.8yrs | CN¥1.89m | no data | |
| Deputy GM & Core Technical Personnel | 5.8yrs | CN¥2.13m | no data | |
| Deputy GM & Core Technical Personnel | 4.4yrs | CN¥1.79m | no data | |
| Senior Director | no data | CN¥1.68m | no data | |
| Core Technical Staff | no data | CN¥488.00k | no data | |
| Core Technical Staff | no data | CN¥687.10k | no data |
3.8yrs
Average Tenure
44yo
Average Age
Experienced Management: 688016's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 6.5yrs | CN¥3.94m | no data | |
| Chairman | 1.2yrs | no data | no data | |
| Employee Representative Supervisor | 6.5yrs | no data | no data | |
| Independent Director | 2.8yrs | no data | no data | |
| Chairman of the Supervisory Board | 1.2yrs | no data | no data | |
| Supervisor | 1.2yrs | no data | no data |
2.0yrs
Average Tenure
40.5yo
Average Age
Experienced Board: 688016's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 20:14 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicroPort Endovascular MedTech Co., Ltd. is covered by 18 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jingning Long | Chasing Securities |
| Jian Jun Zou | Chasing Securities |
| Pei Cheng | China Galaxy Securities Co., Ltd. |